These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14613457)

  • 1. Effects of physician report cards, knowledge of drug prices, and financial incentives in prescription drug costs.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(4):368, 371. PubMed ID: 14613457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Informal conversation with colleagues about drugs, prices, as well as common duties and obligations].
    Hankiss J
    Orv Hetil; 1993 Oct; 134(43):2397. PubMed ID: 8233458
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare Part D: practical and policy implications for family physicians.
    Mallya G; Bazemore A
    Am Fam Physician; 2006 Feb; 73(3):395-6. PubMed ID: 16477884
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug dispensing by physicians: promoter's claims examined.
    Andritz MH; Rogan MP
    Pediatrics; 1988 Sep; 82(3 Pt 2):504-9. PubMed ID: 3405687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can ICER bring cost-effectiveness to drug prices?
    Butcher L
    Manag Care; 2019 Jun; 28(6):30-33. PubMed ID: 31188097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandora's Prescription: The Pharmaceutical Pricing
    Pederson T
    FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
    [No Abstract]   [Full Text] [Related]  

  • 7. How cheap are Canada's drugs really?
    Hollis A
    J Pharm Pharm Sci; 2004 Jun; 7(2):215-6. PubMed ID: 15367378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of side effects. 1: Spontaneous detection of drug risks--responsibility of the physician].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Jul; 109(20):419-20. PubMed ID: 1916567
    [No Abstract]   [Full Text] [Related]  

  • 9. The "American (cancer) patients first" plan to reduce drug prices-A critical assessment.
    Kantarjian H; Light DW; Ho V
    Am J Hematol; 2018 Dec; 93(12):1444-1450. PubMed ID: 30218454
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 11. Are 'indexes' an index of physician performance?
    Howe RB
    Arch Intern Med; 1985 Jan; 145(1):46. PubMed ID: 3970644
    [No Abstract]   [Full Text] [Related]  

  • 12. The ethics and economics of pharmaceutical pricing.
    Parker-Lue S; Santoro M; Koski G
    Annu Rev Pharmacol Toxicol; 2015; 55():191-206. PubMed ID: 25149920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APhA activities. Fighting physician dispensing. A chronology.
    Am Pharm; 1987 Oct; NS27(10):28-32. PubMed ID: 3687721
    [No Abstract]   [Full Text] [Related]  

  • 14. Thoughts on improving medication use.
    Novack GD
    Ocul Surf; 2018 Jan; 16(1):191-195. PubMed ID: 29154840
    [No Abstract]   [Full Text] [Related]  

  • 15. Pricing of prescription drugs and its impact on physicians' choice behavior.
    Miao-Sheng C; Yu-Ti S
    Health Care Manag Sci; 2008 Sep; 11(3):288-95. PubMed ID: 18826006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed budgets as a cost containment measure for pharmaceuticals.
    Granlund D; Rudholm N; Wikström M
    Eur J Health Econ; 2006 Mar; 7(1):37-45. PubMed ID: 16435117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the infectious diseases physician in setting guidelines for antimicrobial use.
    Bryan CS
    Bull N Y Acad Med; 1987; 63(6):627-37. PubMed ID: 3479215
    [No Abstract]   [Full Text] [Related]  

  • 18. [The reference pricing of pharmaceuticals in European countries].
    Gildeyeva GN; Starykh DA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2013; (3):45-9. PubMed ID: 24027849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the availability and cost of medicines in the private sector in Mali].
    Maïga MD; Diawara A
    Med Trop (Mars); 2006 Dec; 66(6):565-8. PubMed ID: 17286022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.